Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 10, 2004, Pages 1091-1097

  Pilotto, A ^a   Franceschi, M ^b   Leandro, G ^c   Paris, F ^a   Cascavilla, L ^a   Longo, M G ^a   Niro, V ^a   Andriulli, A ^a   Scarcelli, C ^a   Di Mario, F ^d  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Ospedale di Schio   (Italy)

^c NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; ESOMEPRAZOLE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; KETOPROFEN; KETOROLAC; LANSOPRAZOLE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PIROXICAM; PROTON PUMP INHIBITOR; RANITIDINE;

AGED; AGING; ARTICLE; CHRONIC DRUG ADMINISTRATION; DRUG ABUSE; DRUG EFFECT; DRUG EFFICACY; DUODENUM ULCER; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RISK REDUCTION; SHORT COURSE THERAPY; STOMACH MUCOSA; STOMACH PROTECTION; STOMACH ULCER;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHRONIC DISEASE; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; PEPTIC ULCER; PROTON PUMPS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 10644264553     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02246.x     Document Type: Article

References (26)

1. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. N Engl J Med 1999: 340: 1888-99.
2. Laine L, Bombardier C, Hawkey CJ, et al. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 2002; 123: 1006-12.
3. Garcia Rodriguez LA, Hernandez-Diaz S. Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs. Am J Epidemiol 2004; 159: 23-31.
4. Pilotto A, Franceschi M, Leandro G, Di Mario F, on behalf of the Geriatric-Gastroenterology Study Group (Società Italiana Gerontologia and Geriatria, SIGG). NSAID and aspirin use by the elderly in general practice. Effect on gastrointestinal symptoms and therapies. Drugs Aging 2003; 20: 701-10.
5. Klotz U. Effect of aging on the pharmacokinetics of gastrointestinal drugs, In: Pilotto, A, Malfertheiner, P, Holt, P, eds. Aging and the Gastrointestinal Tract. Basel: Karger AG Press, 2003: 28-39.
6. Guslandi M, Pellegrini A, Sorghi M. Gastric mucosal defences in the elderly. Gerontology 1999; 45: 206-8.
7. Pilotto A, Franceschi M, Leandro G, Di Mario F, Valerio G. The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly. Eur J Gastroenterol Hepatol 1997; 9: 951-6.
8. Yeomans ND, Karrash JA, Szczepanski L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 1998; 338: 719-26.
9. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with non-steroidal antiinflammatory drugs. N Engl J Med 1998; 338: 727-34.
10. Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs. N Engl J Med 1996; 334: 1435-9.
11. Koch M, Dezi A, Ferrario F, Capurso L. Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials. Arch Intern Med 1996; 156: 2321-32.
12. Leandro G, Pilotto A, Franceschi M, Bertin T, Lichino E, Di Mario F. Prevention of acute NSAID-related gastroduodenal damage. A meta-analysis of controlled clinical trials. Dig Dis Sci 2001; 46: 1924-36.
13. Lanas A, Bajador E, Serrano P, et al. Nitrovasodilators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 2000; 343: 834-9.
14. Pilotto A, Leandro G, Di Mario F, Franceschi M, Bozzola L, Valerio G. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly. A case-control study. Dig Dis Sci 1997; 42: 586-91.
15. Cotton P, Williams CB, Practical Gastrointestinal Endoscopy, 3rd edn. Oxford: Blackwell Scientific Publications, 1990.
16. Chan FKL, Chung SCS, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 967-73.
17. 13C-urea breath test with serology. J Gerontol A Med Sci 2000; 55: M163-7.
18. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257-63.
19. Pilotto A, Franceschi M, Leandro G, et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs. Aging Clin Exp Res 2003; 15: 494-9.
20. Lipscomb GR, Campbell F, Rees WDW. The influence of age, gender, Helicobacter pylori and smoking on gastric mucosal adaptation to nonsteroidal antiinflammatory drugs. Aliment Pharmacol Ther 1997; 11: 907-12.
21. Singh G, Ramey DR. NSAID-Induced gastrointestinal complications: the ARAMIS (Arthritis, Rheumatism and Aging Medical Information System) perspective - 1997. J Rheumatol 1998; 51 (Suppl.): 8-16.
22. Hawkey CJ, Langman MJS. Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut 2003; 52: 600-8.
23. Pilotto A, Di Mario F, Franceschi M, et al. Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. Aliment Pharmacol Ther 2000; 14: 1077-82.
24. Clayton NM, Oakley L, Williams LV, Trevethick MA. The role of acid in the pathogenesis of indomethacin-induced gastric antral ulcers in the rat. Aliment Pharmacol Ther 1996; 10: 339-45.
25. Chan FK, Sung JJ. Role of acid suppressants in prophylaxis of NSAID damage. Baillieres Best Pract Res Clin Gastroenterol 2001; 15: 433-45.
26. Chan FKL, Graham DY. Prevention of non-steroidal anti-inflammatory drug gastrointestinal complications. Review and recommendations based on risk assessment. Aliment Pharmacol Ther 2004; 19: 1051-61.